Lung Cancer Master Protocol (Lung-MAP) Clinical Trials Lung Cancer Master Protocol (Lung-MAP) Clinical Trials logo

Author: Visceral

Associated Press – New Study Aims to Rapidly Test Lung Cancer Drugs

Groundbreaking Collaborative Clinical Trial Launched

For Immediate Release Please Contact: Ryan Hohman, JD, Managing Director, Policy and Public Affairs, Friends of Cancer Research: 202.944.6708 – rhohman@focr.org or Frank DeSanto, Communications Manager, SWOG Cancer Research: 503.348.1710 – desanto@oshu.edu Groundbreaking Collaborative Clinical Trial Launched The Lung-MAP trial uses a multi-drug, targeted screening approach to match patients with promising new cancer treatments based…

CenterWatch: “U.S. cancer researchers launching five-drug personalized medicines trial”

Reuters: “New kind of trial aims to speed cancer drug development”

Genome Web: “Amid Regulatory and Reimbursement Difficulties, Some Encouraging Advancements for Personalized Rx”

ASCO Post: “Activation of Innovative Lung Cancer Master Protocol Officially Announced, Enrollment to Begin in March”

Nature Medicine: “Multicompany Trials Adapt to Disciplines Beyond Cancer”

The Economist: “Getting close and personal: Researchers and drug companies are ganging up for a new push against cancer”

Oncology Times: “Unique Trial Protocol Announced for Lung Cancer”

Pink Sheet: “Lung Cancer ‘Master Protocol’ Eyed As Paradigm-Changing Approach to Drug Development”